KyberSwap integrates PropAMMs via Titan for improved execution
KyberSwap just pulled off something no other DEX aggregator has done. It’s now routing trades through proprietary automated market makers, known as PropAMMs or pAMMs, using Titan Builder as the execution layer.
The integration, which went live on June 1, makes KyberSwap the first DEX aggregator to tap into pAMM liquidity. FermiSwap serves as the initial liquidity source, with Titan’s infrastructure handling the sequencing that makes the whole thing work.
What PropAMMs actually are and why they matter
In technical terms, proprietary AMMs allow market makers to provide liquidity with dynamically updated quotes rather than relying on static bonding curves. The result is pricing that more closely reflects current market conditions, which means tighter spreads and less slippage for the person making the trade.
The challenge with pAMMs has always been execution timing. If a market maker updates their quote but a user’s transaction gets processed before that update hits the chain, you end up with stale pricing. That’s where Titan Builder comes in.
Titan enables application-controlled execution sequencing, ensuring the most recent pAMM quote updates are processed before user transactions, so traders are always getting prices based on the freshest data available.
The numbers so far
Currently, about 15% of KyberSwap’s quote routing pulls from pAMM sources. The supported pairs at launch are WETH/USDT and WETH/USDC, with additional pairs on the roadmap, including USDC/USDT and various WBTC combinations.
KyberSwap has also layered on its Smart Settlement feature as a safeguard. This system compares on-chain execution outcomes against expected results, flagging situations where high slippage or potential spoofing might compromise a trade.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Revenue and profit guidance exceeds expectations across the board! Without Jensen Huang, is Nvidia (NVDA.US) still maintaining its AI narrative as usual?
Nvidia raised its performance guidance, while also denying the possibility of Jensen Huang's return.
Microsoft (MSFT.US) Ignite Conference Releases Six Dedicated AI Models: Challenging OpenAI and Anthropic with Lower Costs
Microsoft is making significant progress in building its own cutting-edge general-purpose AI models and has launched six dedicated AI models at the Ignite conference.

A key return for the $10.6 billion acquisition! GlaxoSmithKline (GSK.US) lung cancer drug Nelkarmi approved for market launch, targeting a multi-billion dollar market
The lung cancer drug neladalkib from GlaxoSmithKline has been approved for market by the US Food and Drug Administration (FDA), further validating the strategic value of the British pharmaceutical company's previous acquisition of the biotechnology company Nuvalent.
Hyperliquid revenue diversification rises as $4B daily volume shifts from crypto to stocks

